(Q40865245)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918608%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

The consequence of p53 overexpression for liver tumor development and the response of transformed murine hepatocytes to genotoxic agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918608%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

1 reference

Claude Caron De Fromentel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918608%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

Virginie Joulin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918608%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

author name string

R Gillet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918608%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

G Grimber

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918608%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

M Bennoun

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918608%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

P Briand

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918608%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

language of work or name

English

0 references

publication date

1 July 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918608%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918608%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918608%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918608%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

3498-3507

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918608%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1203671

8 November 2019

exact match

0 references

cites work

Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

UV but not gamma-irradiation induces specific transcriptional activity of p53 in primary hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

Requirement for p53 and p21 to sustain G2 arrest after DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

A p53-dependent mouse spindle checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

A genetic model for colorectal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

Excess wild-type p53 blocks initiation and maintenance of simian virus 40 transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

Wild-type p53 can down-modulate the activity of various promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

Association of loss of heterozygosity at the p53 locus with chemoresistance in osteosarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

Drug-resistant breast cancer cells frequently retain expression of a functional wild-type p53 protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

Adenovirus-mediated p53 gene therapy has greater efficacy when combined with chemotherapy against human head and neck, ovarian, prostate, and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

p53 regulation by post-translational modification and nuclear retention in response to diverse stresses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

Identification of p53 as a sequence-specific DNA-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

Wild-type p53 is a cell cycle checkpoint determinant following irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

New functional activities for the p21 family of CDK inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

Cancer. p53, guardian of the genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

Characterization of the p53-dependent postmitotic checkpoint following spindle disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

The p53 tumour suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

A transgenic mouse model for mammary carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

An apoptotic defect in lens differentiation caused by human p53 is rescued by a mutant allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

Human lymphoblastoid cell lines expressing mutant p53 exhibit decreased sensitivity to cisplatin-induced cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

Wild-type p53 binds to the TATA-binding protein and represses transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

Simian virus 40 large T antigen binds a novel Bcl-2 homology domain 3-containing proapoptosis protein in the cytoplasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

p53 function and dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

Wild-type p53 activates transcription in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

Testicular wild-type p53 expression in transgenic mice induces spermiogenesis alterations ranging from differentiation defects to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

7 January 2021

p53 Deficiency in liver reduces local control of survival and proliferation, but does not affect apoptosis after DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

7 January 2021

The amino-terminal region of SV40 large T antigen is sufficient to induce hepatic tumours in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

7 January 2021

Acute overexpression of wt p53 facilitates anticancer drug-induced death of cancer and normal cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

7 January 2021

Time-course development of differentiated hepatocarcinoma and lung metastasis in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

7 January 2021

The mouse equivalent of the human p53ser249 mutation p53ser246 enhances aflatoxin hepatocarcinogenesis in hepatitis B surface antigen transgenic and p53 heterozygous null mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

7 January 2021

Wild-type p53 transgenic mice exhibit altered differentiation of the ureteric bud and possess small kidneys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

7 January 2021

Suppression of interleukin-1beta converting enzyme (ICE)-induced apoptosis by SV40 large T antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

7 January 2021

Japan split over US aid for spy satellites

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

7 January 2021

Prevention of mammalian DNA reduplication, following the release from the mitotic spindle checkpoint, requires p53 protein, but not p53-mediated transcriptional activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

7 January 2021

p53-dependent apoptosis suppresses tumor growth and progression in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

7 January 2021

A 700-bp fragment of the human antithrombin III promoter is sufficient to confer high, tissue-specific expression on human apolipoprotein A-II in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

7 January 2021

Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203671

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1203671

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10918608%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

8 November 2019

1041851072

0 references

1 reference